Dyadic International Inc (DYAI) Stock Analysis
Sector: HEALTHCARE - BIOTECHNOLOGY
Exchange: NASDAQ
Key Metrics
- Price: $0.78
- Market Cap: $32.75M
- EPS: $-0.19
- 52-Week High: $1.55
- 52-Week Low: $0.71
About Dyadic International Inc
Dyadic International, Inc. is a leading biotechnology platform company based in Jupiter, Florida, specializing in the development and production of enzymes and recombinant proteins tailored for diverse applications within the life sciences sector. Utilizing its proprietary C1 cell protein production platform, Dyadic enhances the efficiency and cost-effectiveness of biopharmaceutical manufacturing, catering to the increasing global demand for biologics such as therapeutic proteins and vaccines...
GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Dyadic International Inc and 4,500+ other companies. Learn more about GNG Pro.
Frequently Asked Questions
Does DYAI pay dividends?
Dyadic International Inc (DYAI) does not currently pay a regular dividend.
What is DYAI's market cap?
Dyadic International Inc (DYAI) has a market capitalization of $32.75M with a current stock price of $0.78.